99 related articles for article (PubMed ID: 6236861)
1. Clinical and biochemical effects of long-term vitamin A administration to a patient with Hurler-Scheie compound.
Wannmacher CM; Wajner M; Giugliani R; Costa MG; Giugliani ER; Castro JZ
Braz J Med Biol Res; 1984; 17(1):43-7. PubMed ID: 6236861
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of urinary glycosaminoglycans excreted by a patient with the Hurler-Scheie compound syndrome.
Kimura A; Hayashi S; Koseki M; Tsurumi K
Tohoku J Exp Med; 1982 Jan; 136(1):61-6. PubMed ID: 6803394
[TBL] [Abstract][Full Text] [Related]
3. The effect of fasting and time of day on the urinary excretion of chondroitin 4/6 sulphate, dermatan sulphate and four chondroitinase ABC resistant glycosaminoglycans.
Poulsen JH; Gregersen H
Scand J Clin Lab Invest; 1983 Dec; 43(8):665-70. PubMed ID: 6420878
[TBL] [Abstract][Full Text] [Related]
4. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
[TBL] [Abstract][Full Text] [Related]
5. Chemical definition of the mucopolysaccharidoses.
Constantopoulos G; Dekaban AS
Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
Satake S; Ototani N; Isemura M; Yosizawa Z
Tohoku J Exp Med; 1983 May; 140(1):89-96. PubMed ID: 6408765
[TBL] [Abstract][Full Text] [Related]
7. Determination of glycosaminoglycans composition in the urine of children in reference to the clinical picture of mucopolysaccharidoses.
Gadowska M; Dawydzik B
Mater Med Pol; 1983; 15(1-2):24-30. PubMed ID: 6443627
[No Abstract] [Full Text] [Related]
8. Effects of vitamins A and C on urinary excretion of acid mucopolysaccharides in the Hurler's syndrome.
Onisawa J; Lee TY
Paediatr Univ Tokyo; 1970 Jan; 17():23-4. PubMed ID: 4246081
[No Abstract] [Full Text] [Related]
9. Diagnosis of genetic mucopolysaccharidoses: electrophoretic and enzymatic characterization of urinary glycosaminoglycans.
Taniguchi N; Koizumi S; Masaki K; Kobayashi Y
Biochem Med; 1975 Nov; 14(3):241-9. PubMed ID: 131549
[No Abstract] [Full Text] [Related]
10. Clinical ultrastructural and tissue culture studies in a possible compound Hurler-Scheie case.
Tondeur M; Vamos-Hurwitz E; Cantz M; Cremer N; Libert J; Pardou A
Acta Paediatr Belg; 1976; 29(2):109-15. PubMed ID: 826105
[No Abstract] [Full Text] [Related]
11. [Glycosaminoglucuronates and their fractions in the urine of patients with scleroderma].
Kowalczyk J; Oszewska Z
Przegl Dermatol; 1978; 65(5):527-33. PubMed ID: 725096
[No Abstract] [Full Text] [Related]
12. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary excretion of acid mucopolysaccharides and glycopeptides in hypothyroidism following thyroid hormone therapy.
Tokoro T; Eto Y
Eur J Pediatr; 1985 May; 144(1):84-6. PubMed ID: 3160592
[TBL] [Abstract][Full Text] [Related]
14. Separation of dermatan sulfate from heparan sulfate in mucopolysaccharidosis urine by chromatography on Sephadex G-75.
Herd JK; Forrest T; Tschida J
Clin Chim Acta; 1976 Apr; 68(1):1-9. PubMed ID: 131009
[TBL] [Abstract][Full Text] [Related]
15. Isolation, identification, and quantitation of urinary glycosaminoglycans.
Lee EY; Kim SH; Whang SK; Hwang KY; Yang JO; Hong SY
Am J Nephrol; 2003; 23(3):152-7. PubMed ID: 12646785
[TBL] [Abstract][Full Text] [Related]
16. Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma.
Hennessey PT; Hurst RE; Hemstreet GP; Cutter G
Cancer Res; 1981 Oct; 41(10):3868-73. PubMed ID: 6793229
[TBL] [Abstract][Full Text] [Related]
17. Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.
Erkurt B; Ilker Y; Budak Y; Ozveren B; Türkeri L; Akdas A
J Endourol; 1999 Oct; 13(8):553-7. PubMed ID: 10597124
[TBL] [Abstract][Full Text] [Related]
18. Paired observations of sulphate/uronic acid ratios in glycosaminoglycans of human dermis and urine.
Poulsen JH; Cramers MK
Scand J Clin Lab Invest; 1982 Apr; 42(2):107-12. PubMed ID: 6813943
[TBL] [Abstract][Full Text] [Related]
19. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. I. Urinary hydroxyproline and glycosaminoglycan excretion during fracture repair.
Kustos G
Acta Chir Acad Sci Hung; 1979; 20(1):69-78. PubMed ID: 554381
[No Abstract] [Full Text] [Related]
20. Noninvasive diagnosis of tubular damage by the use of urinary chondroitin-4-sulfate/heparan sulfate ratio.
Lubec G; Kircher S
Nephron; 1986; 42(4):340. PubMed ID: 2938022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
